HALISTER: Amgen Wins Ban on Sanofi’s Sales of Praluent Cholesterol Drug

Amgen Wins Ban on Sanofi’s Sales of Praluent Cholesterol Drug

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
AMGN US (Amgen Inc)
REGN US (Regeneron Pharmaceuticals Inc)
SAN FP (Sanofi)

People
Sue Robinson (United States District Court of Delaware)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283